Cardiac Troponin Levels in Patients with Chronic Kidney Disease: "Markers of High Risk or Just Noise''?

Eleni V Geladari1, Natalia G Vallianou2, Angelos Evangelopoulos3

  • 1Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou Str., 10676 Athens, Greece.

PubMed

Insights

Chronic kidney disease (CKD) patients often show elevated cardiac troponins (cTnT and cTnI), which can be confusing. This review clarifies why CKD causes high troponin levels and when intervention is needed.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarker Research

Background:

  • Cardiovascular disorders are a major cause of mortality in patients with kidney disease.
  • Early detection of myocardial damage is crucial for managing cardiovascular complications in this high-risk group.
  • Cardiac troponins (cTnT and cTnI) are established biomarkers for myocardial injury and acute myocardial infarction.

Purpose of the Study:

  • To explore the underlying reasons for elevated troponin levels in patients with chronic kidney disease.
  • To provide guidance on interpreting elevated troponin levels in CKD patients.
  • To determine when elevated troponin levels in CKD necessitate urgent clinical intervention.

Main Methods:

  • Review of existing literature on cardiac troponin levels in chronic kidney disease.
  • Analysis of factors contributing to myocardial damage and troponin elevation in CKD.
  • Clinical interpretation of elevated troponin values in the context of cardiovascular risk in CKD.

Main Results:

  • Elevated cardiac troponin (cTnT and cTnI) levels are frequently observed in asymptomatic patients with chronic kidney disease.
  • These elevations can stem from various factors related to CKD, not solely acute myocardial infarction.
  • Distinguishing between CKD-related elevations and true cardiac events is clinically challenging.

Conclusions:

  • Elevated troponins in CKD patients require careful interpretation due to potential non-ischemic causes.
  • Understanding the specific context of CKD is vital for appropriate clinical decision-making.
  • Further research is needed to refine the diagnostic and prognostic utility of troponins in CKD.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
58
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.2K